Drug & medication recalls Moderate risk

Labetalol HCl 5 mg/mL 20 mg/ Fill in a Single Dose Syringe recalled over sterility concerns

Recall date
September 12, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
KRS Global Biotechnology, Inc recalls Labetalol HCl 5 mg/mL 20 mg/4 mL (5 mg/mL) 4 mL Fill in a 6 mL Single Dose Syringe, Rx only, KRS Global Biotechnology 7…
Recall number
D-0066-2020
FDA classification
Class II
Brand / firm
KRS Global Biotechnology, Inc
Sold / distributed
Nationwide

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Labetalol HCl 5 mg/mL 20 mg/4 mL (5 mg/mL) 4 mL Fill in a 6 mL Single Dose Syringe, Rx only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676419

Get recall alerts

Free email alert whenever KRS Global Biotechnology, Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: KRS Global Biotechnology, Inc